Cover Image

Experimental and Applied Immunotherapy

Immunotherapy is now recognized as an essential component of treatment for a wide variety of cancers. It is an interdisciplinary field that is critically dependent upon an improved understanding of a vast network of cross-regulatory cellular populations and a diversity of molecular effectors; it is...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Medin, Jeffrey. (Editor, http://id.loc.gov/vocabulary/relators/edt), Fowler, Daniel. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2011.
Edition:1st ed. 2011.
Subjects:
Immunology.
Cell biology.
Cell Biology.
Online Access:https://doi.org/10.1007/978-1-60761-980-2
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Foreword, by Carl H. June, M.D.
  • Chapter 1: Extending the Use of Adoptive T Cell Immunotherapy for Infections and Cancer
  • Chapter 2: B Lymphocytes in Cancer Immunology
  • Chapter 3: Monoclonal Antibody Therapy for Cancer
  • Chapter 4: Natural Killer Cells for Cancer Immunotherapy
  • Chapter 5: Dendritic Cell Based Cancer Vaccines: Practical Considerations, by Elizabeth Scheid, Michael Ricci
  • Chapter 6: Mesenchymal Stromal Cells: an Emerging Cell-based Pharmaceutical
  • Chapter 7: Tumor-specific Mutations as Targets for Cancer Immunotherapy
  • Chapter 8: Counteracting Subversion of MHC Class II Antigen Presentation by Tumors
  • Chapter 9: Mechanisms and Implications of Immunodominance in CD8+ T-Cell Responses
  • Chapter 10: T Regulatory Cells and Cancer Immunotherapy
  • Chapter 11: Negative Regulators in Cancer Immunology and Immunotherapy
  • Chapter 12: Genetically Engineered Antigen Specificity in T Cells for Adoptive Immunotherapy
  • Chapter 13: Cytokine Immunotherapy
  • Chapter 14: Transcriptional Modulation using Histone Deacetylase Inhibitors for Cancer Immunotherapy
  • Chapter 15: Combining Cancer Vaccines with Conventional Therapies
  • Chapter 16: Combining Oncolytic Viruses with Cancer Immunotherapy
  • Chapter 17: XRT and Immune Therapy
  • Chapter 18: Assessing Immunotherapy through Cellular and Molecular Imaging
  • Chapter 19: Converging Themes in Allogeneic and Autologous Transplantation.

Similar Items